Fetal Outcomes Among Women with Asthma during Pregnancy: Evidence from a Large Healthcare Database in the United States - 05/02/19
Doi : 10.1016/j.jaci.2018.12.949
Jennifer J. Yland, Ms.MS 1, Brian Bateman, Dr.MD MSc 2, 3, Krista F. Huybrechts, Dr.MS PhD 2, Michael Schatz, Dr.MD MS FAAAAI 4, Keele Wurst, Dr.PhD RPh 5, Sonia Hernández-Díaz, Dr. 1
1 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
2 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
3 Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
4 Department of Allergy, Kaiser Permanente Medical Center, San Diego, CA
5 Department of Epidemiology and Real-World Evidence, GlaxoSmithKline, Collegeville, PA
L5
Le texte complet de cet article est disponible en PDF.Plan
© 2018
Publié par Elsevier Masson SAS.
Vol 143 - N° 2S
P. AB422 - février 2019 Retour au numéro
Article précédent
- Efficacy and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from the Randomized Phase 3 Sinus-24 Study
- Joseph K. Han, Claus Bachert, Martin Desrosiers, Tanya M. Laidlaw, Claire Hopkins, Wytske J. Fokkens, Pierluigi Paggiaro, Seong Ho Cho, Heidi Olze, Leon S. Greos, Mei Zhang, Chunpeng Fan, Steven Draikiwicz, Nikhil Amin, Siddhesh Kamat, Asif Khan, Gianluca Pirozzi, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda P. Mannent
- Biomarkers and Outcomes in Omalizumab-Treated Patients with Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)
- Benjamin Ortiz, Abhishek Kavati, Maryia Zhdanava, Jason Lecocq, Bradd Schiffman, Dominic Pilon, Harriet Ho, Brian D. Stone
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?